A common bacteria ever-present on the human skin and previously considered harmless, may, in fact, be the culprit behind chronic sinusitis, a painful, recurring swelling of the sinuses that strikes more than one in ten Americans each year, according to a study by scientists at the University of California, San Francisco.
[More]
Massachusetts General Hospital (MGH) surgeons have developed a new technique for reconstructing the larynx after surgery for advanced cancer.
[More]
Patients who have undergone sinus surgery can safely take an alternative pain medication that does not cause the side effects of narcotics such as fentanyl and Vicodin, a Loyola University Health System study has found.
[More]
The American Academy of Cosmetic Surgery (AACS) announced its highest attendance in the Academy’s history with more than 700 medical professionals at its 28th Annual Scientific Meeting. The event was held January 18-21, 2012 at Caesars Palace Hotel in Las Vegas.
[More]
Ian Humphreys, Sonal Saraiya, Walter Belenky and James Dworkin, at Detroit Medical Centre in Michigan proceeded to treat a four year old girl who had a rare hereditary disorder that brings prolonged bleeding, publishing their findings in the Annals of Otology, Rhinology and Laryngology.
[More]
The 2011 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 11-14, 2011, in San Francisco, CA.
[More]
The corpus delicti is a plain flacon from among the possessions of Pharaoh Hatshepsut, who lived around 1450 B.C., which is on exhibit in the permanent collection of the Egyptian Museum of the University of Bonn. For three and a half millennia, the vessel may have held a deadly secret. This is what the Head of the collection, Michael H-veler-M-ller and Dr. Helmut Wiedenfeld from the university's Pharmacology Institute just discovered.
[More]
New research shows that the levels of dog allergens don't appear to be very different in houses with hypoallergenic dogs than in those with other dogs.
[More]
Contrary to popular belief, so-called hypoallergenic dogs do not have lower household allergen levels than other dogs.
[More]
Surgical approaches that reduce incision size and recovery time from thyroid surgery work well in children, physician-scientists report.
[More]
Results published in the January/February, 2011 issue of International Forum of Allergy & Rhinology demonstrate that patients with chronic rhinosinusitis who receive treatment with balloon sinus dilation can experience significant improvement in work productivity.
[More]
Manuel Don, Ph.D., is a principal investigator in the Division of Communication and Auditory Neuroscience at the House Ear Institute. Dr. Don joined the House Ear Institute in 1976 after working as an assistant research auditory physiologist at the University of California, Irvine.
[More]
Today OptiNose Inc. announced the positive results of a study evaluating the efficacy of fluticasone when delivered by the Company's novel bi-directional technology in patients with refractory chronic rhinosinusitis (CRS). The results of the study have been published in an article in the September issue of Rhinology.
[More]
OptiNose Inc. announced today that a subgroup analysis of positive Phase II trial results has been published in the July/August issue of the American Journal of Rhinology & Allergy.
[More]
Faculty of 1000 Biology, the award-winning literature awareness service for the life sciences, has launched the much anticipated Otolaryngology Faculty.
[More]
A recently published study in the American Journal of Rhinology and Allergy demonstrates Balloon Sinuplasty™ technology to be safe when used by physicians in pediatric patients. Known as the INTACT study, this is a prospective, non-randomized, multicenter study and was sponsored by Acclarent, Inc.
[More]
OptiNose is pleased to announce the publication of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the topical treatment of chronic rhinosinusitis with nasal polyps in Rhinology, the official journal of the International and European Rhinologic Societies.
[More]
A new study suggests that a growing segment of patients are turning to complementary and alternative medical therapies to help treat the symptoms of chronic rhinosinusitis (CRS).
[More]
OptiNose has announced important new results from a Phase II trial of its novel nasal drug delivery device with fluticasone for the treatment of chronic rhinosinusitis.
[More]
A hot drink may help reduce the symptoms of common colds and flu, according to new research by Cardiff University's Common Cold Centre.
[More]